Pancreatic cancer is deadly, and its toll is growing. Scientists find that scar tissue around the tumor suggests how long a patient will live after diagnosis.
Cancer neuroscience discoveries give hope
To drive their growth, many tumors hijack nervous system signals, including those needed for brain plasticity. Stanford Medicine discoveries are opening a promising new branch of oncology research.
African Americans less likely to be screened
National guidelines for lung cancer screening are less effective for African Americans than for whites, Stanford study concludes. A risk-based analysis is more equitable and effective.
Lung cancer cells protected by brain cells
Small cell lung cancers often metastasize to the brain. A Stanford Medicine study shows they thrive there by emulating developing neurons and recruiting surrounding cells for protection.
Reena Thomas gets $12 million CIRM grant
The award will facilitate a clinical trial testing the safety of CAR-T cells — immune cells from patients’ own bodies that have been bioengineered to destroy cancer cells — used to treat a deadly brain cancer.
Arc Institute awards
Two professors are named Innovation Investigators, and four win Ignite Awards.
Big Ideas in Medicine
Physicians, researchers and other pacesetters describe some of the most promising pursuits in the medical field. In cancer, for instance: ‘Let’s kill the first cell, not the last cell.’…
Real-time targeting of tumors
New technology combines radiotherapy with real-time detection of cancer cells to target moving tumors or multiple metastases. Stanford Medicine is the first to research the technology in the clinic.
AI could inform brain cancer prognosis
Stanford Medicine scientists and colleagues create an algorithm that could help physicians better understand and target complicated brain tumors.
Tumor suppressor repairs tissue
The tumor suppressor p53 has been in the limelight for decades. But its cancer-fighting function may be only a side effect of its role in tissue repair, a Stanford Medicine study finds.
Cancer center renovation
The Laurie K. Lacob Pavilion at the Stanford Medicine Cancer Center opened July 17. The state-of-the-art facility, for transplant and cellular therapies, is a light-filled space for healing.
Predictable mutations chart cancer’s path
Human cells evolving in the laboratory undergo a series of predictable, sequential genetic changes that lead to pre-cancer. Blocking these changes may allow intervention before cancer occurs.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Blood Disorders (Hematology)
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Environment & Sustainability
- Epidemiology & Population Health
- Global Health
- Health Policy
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Neurology & Neurosurgery
- Obstetrics & Gynecology
- Palliative Care
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Stanford Medicine
- Stem Cells
- Women's Health